Droplet IV to Launch Revolutionary Automatic IV Flushing Device in 2026
Droplet IV: A Leap in IV Care Technology
In a significant stride for infusion care, Droplet IV has successfully closed a $2 million funding round which is set to enable the launch of its innovative automatic intravenous (IV) flushing device. Slated for debut in 2026, this device aims to streamline a process that has been historically manual and time-consuming for nursing staff. The effective environmental challenges faced in medical settings due to the excessive manual flushing of IV lines underline the necessity for this technological advancement.
The successful funding round marks a pivotal moment for Droplet IV, being its first external investment. Leading the charge are notable stakeholders from the health sector, including former ConvaTec executive John Lindskog, family office members with extensive MedTech expertise, and seasoned angel investors with backgrounds in nursing and clinical operations. “The clinical significance of Droplet IV's technology is apparent,” states Lindskog.